No Data
iRay Technology (688301.SH): Hainan He Yi has completed a Shareholding reduction of 2%.
iRay Technology (688301.SH) issued an announcement, recently, the company received notification from Hainan Heyi regarding "About iRay Technology..."
Express News | Iray Technology Says Shareholders and Director Plan to Offload up to 0.92% Stake in Company in Total Within 3 Months
Multiple Shareholders of iRay Technology (688301.SH) plan to collectively reduce their Shareholding by no more than 1.3177 million shares.
iRay Technology (688301.SH) announced that its shareholders Shanghai Changze and Shanghai Changrui intend to engage in Trade through block trading...
iRay Technology (688301.SH) plans to invest 40 million yuan in its holding subsidiary iRay Power to advance the development of the digital X-ray imaging core components Industry Chain.
iRay Technology (688301.SH) announced that the company plans to use its own funds to invest in its subsidiary iRay Power Technology (Shanghai...
iRay Technology (688301.SH): Completed the integration goal of the Computed Tomography detector and subsystem, and sent samples for testing.
According to the investor interaction platform on December 24, Gelonghui reported that iRay Technology (688301.SH) stated that, based on QY Research's relevant survey statistics, the sales of the global Computed Tomography detector market reached 7.9 billion yuan in 2023, with an expected increase to 12.6 billion yuan by 2030, achieving a compound annual growth rate (CAGR) of 6.9%. Regarding Medical Computed Tomography detectors, the company has completed the development of key components such as gadolinium oxysulphide scintillator ceramic (GOS), collimators (ASG), and photodiodes (PD), and together with customized readout chips, achieved the goal of integrating the Computed Tomography detector and subsystems.
iRay Technology (688301.SH): Actively expanding the Business of new core components such as high-voltage generators, tube balls, and integrated radiation source solutions.
On December 24, Gelonghui reported that iRay Technology (688301.SH) stated on the investor interaction platform that since the second half of 2023, the global slowdown in macroeconomic growth and the reorganization of the Medical Industry have affected the rhythm of equipment procurement. The procurement and bidding by Medical Institutions have gradually slowed down, with some Medical Institutions delaying their procurement plans. Additionally, the equipment update policies proposed by the state for the first half of 2024 have not yet been implemented. As a result, the market demand for X-ray imaging equipment is not strong, and the company’s performance is under short-term pressure, impacting the company's stock price. However, in the long term, digital X-ray imaging equipment and its core components are essential for medical diagnosis and treatment.
After Leaping 35% IRay Technology Company Limited (SHSE:688301) Shares Are Not Flying Under The Radar
